The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer.
about
Chemo-genetic optimization of DNA recognition by metallodrugs using a presenter-protein strategy1-Acetyl-3-ferrocenyl-5-(2-nitro-phen-yl)-2-pyrazoline.1-Acetyl-5-ferrocenyl-3-phenyl-2-pyrazoline.4'-Ferrocenyl-1'-methylacenapthylene-1-spiro-2'-pyrrolidine-3'-spiro-2''-indane-2,1'',3''(1H)-trione.19-Ferrocenyl-18-oxa-8,16-diaza-penta-cyclo-[8.6.3.0.0.0]nona-deca-2(7),3,5-triene-9,17-dioneOrganometallic anticancer compoundsHalf-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexesVectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studiesOn the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy(E)-1-Ferrocenyl-3-[2-(2-hy-droxy-eth-oxy)phen-yl]prop-2-en-1-one.2-Ferrocenyl-3-nitro-2H-chromeneMedicinal organometallic chemistry: designing metal arene complexes as anticancer agents.Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs.Metallocenes as Target Specific Drugs for Cancer Treatment.Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.Current State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases.Ferrocene-containing non-interlocked molecular machines.The conjugates of ferrocene-1,1'-diamine and amino acids. A novel synthetic approach and conformational analysis.Some ferrocenyl chalcones as useful candidates for cancer treatment.Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species.Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells.Synthesis and biological activity of cymantrene and cyrhetrene 4-aminoquinoline conjugates against malaria, leishmaniasis, and trypanosomiasis.Impact of metal on the DNA photocleavage activity and cytotoxicity of ferrocenyl terpyridine 3d metal complexes.Organometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells.Synthesis, electrochemical studies and anticancer activity of ferrocenyl oxindoles.Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol.Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity.A series of unconjugated ferrocenyl phenols: prospects as anticancer agents.4-Ferrocenyl-1-methyl-3-benzoyl-spiro-[pyrrolidine-2,11'-indeno-[1,2-b]quinoxaline].2-(4-Bromo-benzo-yl)-1-ferrocenyl-spiro-[11H-pyrrolidizine-3,11'-indeno-[1,2-b]quinoxaline].6-Ferrocenoyl-7-phenyl-spiro-[hexa-hydro-pyrrolo-[1,2-c][1,3]thia-zole-5,11'-indeno-[1,2-b]quinoxaline].6-Ferrocenoyl-7-(4-fluoro-phen-yl)spiro-[hexa-hydro-pyrrolo-[1,2-c][1,3]thia-zole-5,11'-indeno-[1,2-b]quinoxaline].3'-Ferrocenylcarbon-yl-1'-methyl-4'-phenyl-spiro-[indeno-[2,3-b]quinoxaline-11,2'-pyrrolidine].3-(Ferrocen-1-ylcarbon-yl)-1-methyl-4-(4-methyl-phen-yl)spiro-[pyrrolidine-2,11'-indeno-[1,2-b]quinoxaline].2-[5-(1,3-Benzodioxol-5-yl)-3-ferrocenyl-4,5-dihydro-1H-pyrazol-1-yl]-4-phenyl-1,3-thia-zole.Deciphering the activation sequence of ferrociphenol anticancer drug candidates.[(η(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity.Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure-activity relationship study.Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
P2860
Q27664742-130001BF-2D6D-432F-8C69-03C9E1234253Q34227792-D5A6B9B6-7E87-48E7-8A1F-0350D3D6D99DQ34261095-80DBA180-8BDE-49C7-9BE2-B303EC61BDA4Q34273240-38C4E658-F656-45F6-8AF0-16C991F81E31Q34446267-26B8A317-542B-4617-A628-07FA53B7B683Q34476685-CED314D6-B78C-4842-9F3D-49CD7DFCD9B7Q35034267-07666B5A-0816-462F-A879-CCECF0CB4C9EQ35705862-F9582B32-4342-419A-92D4-38B83A01BDACQ36107216-9B2318B9-E0EF-4D52-92BB-4EE6B5AAAF96Q36657378-5E74CC41-54BB-4EFC-9702-FE8D23D915E6Q37168927-258CE087-A77D-49EE-81F4-D2F43C336F14Q37246984-E765B3A9-F2D8-41B4-91FF-7BBA11C15EC6Q38011996-A7032095-082A-4D05-8ED0-C96F2AE8DB1EQ38062521-10C54FB3-C361-4E19-99D7-12B19B4FD252Q38199383-3299B9E6-6178-4907-A247-89D5A7D3A487Q38669290-BC9DA4C4-AB7A-4113-90D8-1BC712EC8770Q38688208-96083276-C755-4A0B-A16C-F23805BD8AD9Q38840687-8BC7E8F6-1BE5-47FE-AD84-D6F137E3454CQ38870117-A206F941-3C58-4E57-9A9B-1D538B2BF667Q39096632-2CD637B8-BB35-49EC-9397-479FCA729217Q39346477-84860A55-790D-499F-A5D9-A073F472DE51Q39378935-F167D994-0EDD-4D66-90B1-2FEFEA0E0171Q39462812-761D055D-5676-43C6-8C2E-3EE0FD936749Q39682941-A0E1C041-4235-4A4C-9338-9F3B5B805B8CQ39684386-F7D1A5E2-38A0-4CF4-8FE1-DE40D859F19DQ39761075-4C3745DC-6F4E-4399-A330-BA9E2BD9C2BFQ39815615-16E6B18D-8158-4226-97BF-F13BA4A2E8DFQ40223467-3E2BBAAD-1DEA-46F3-A35E-9D008D006DEFQ40246541-FFF9B69B-25FE-4688-922A-84881399BF5BQ41587838-1C82610D-833A-49E5-AF09-F9120E68B8F3Q41857800-89FE3BFF-0451-4055-9843-4E3F9D7C3720Q41857817-6613693E-A23C-4B5A-BD75-3C248A5D23EDQ41857873-AA5D2019-0C44-463C-B829-C46784B842A4Q41861593-FEA65762-0700-4B20-AD0E-DAFC6CF98206Q41892984-1BF4672C-1CD9-491C-9303-3CFD83A0FCE1Q42359741-DB1A302A-3C7F-4283-B51C-C408A06C365FQ44853406-5B02F5D3-103D-4726-952F-6B31F9B2D75EQ45340054-E25CE94F-8D57-4A11-AD50-3DFBD23A842BQ46425575-B3DDA110-FB33-46BD-988D-8ABEC63AFAC8Q46454070-FD777363-B102-46DF-A06F-0B8DB718BF87
P2860
The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The first organometallic selec ...... ir relevance to breast cancer.
@ast
The first organometallic selec ...... ir relevance to breast cancer.
@en
type
label
The first organometallic selec ...... ir relevance to breast cancer.
@ast
The first organometallic selec ...... ir relevance to breast cancer.
@en
prefLabel
The first organometallic selec ...... ir relevance to breast cancer.
@ast
The first organometallic selec ...... ir relevance to breast cancer.
@en
P2093
P356
P1476
The first organometallic selec ...... ir relevance to breast cancer.
@en
P2093
Anne Vessières
G Leclercq
Gérard Jaouen
Michael J McGlinchey
P304
P356
10.2174/0929867043364487
P577
2004-09-01T00:00:00Z